Search

everythinglearnresearchcommunity

for

Search:↓

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

AR gene not major factor in female hair loss; different from male hair loss.

Insulin resistance is found in 20% of Thai women with PCOS, with age, waist size, skin changes, and abnormal blood fats increasing the risk.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

PCOS is a common hormonal disorder with symptoms like irregular periods and excess hair growth, managed with lifestyle changes and medications.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

STK11 gene polymorphism does not predict metformin response in PCOS.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

High prolactin levels can cause skin and hair symptoms similar to those caused by hormone imbalances.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

A girl with Becker naevus syndrome has a genetic variant in the ACTB gene related to her symptoms.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Hair loss requires customized treatments based on its various causes and types.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.